Oregon Health & Science University runs 53 ORs across 4 sites and performs nearly 39,000 cases a year. With financial pressure and rising surgical volume, perioperative leaders needed a faster, more reliable way to staff rooms and sustain morale. This…
Presented by:
Regional anesthesia is moving from “nice to have” to a core component of orthopedic care by easing pain, accelerating recovery and expanding what’s possible in outpatient surgery. Yet many groups leave clinical and financial value on the table due to…
Presented by:
The Doylestown (Penn.) Surgery Center has closed, leaders confirmed to Becker’s Oct. 30. The ASC was jointly owned by Doylestown Hospital, Philadelphia-based Jefferson Health, Rothman Orthopaedics, Leawood, Kan.-based NueHealth and 10 surgeons. “Rothman remains deeply committed to providing world-class access…
Nearly half of hospital revenue cycle leaders say denials are their top financial concern — outranking labor shortages, reimbursement cuts and analytics gaps. While many teams focus on rework, high-performing hospitals are looking upstream. This short report offers 10 strategies…
Presented by:
How proactive CFOs are protecting revenue, strengthening compliance, and preparing for sweeping Medicaid changes Q1 2026 is coming fast—and with it, Medicaid cuts, tighter margins, and new documentation and compliance requirements. Hospitals in ACA expansion states and rural communities face…
Presented by:
Here are six leadership appointments in the ASC industry since Oct. 2, as reported by Becker’s: 1. UnitedHealth Group’s Optum, parent company of ASC chain SCA Health, named Ben Eklo chief financial officer, effective Nov. 1. He will replace Roger…
Managing locum tenens at scale is rarely efficient. For one Mid-Atlantic academic medical center, a fragmented approach led to high costs, siloed departments and internal competition for providers. But a centralized, vendor-neutral strategy changed everything. By overhauling its locum tenens…
Presented by:
More than 200 industry leaders have spoken: the 2025 Trends in Specialty Drug Benefits Report, co-sponsored by Genentech and Pharmaceutical Strategies Group (PSG), is here. This executive summary captures how payers are resetting specialty drug strategies and what that means…
Presented by:
In today’s healthcare environment, labor costs can determine whether a health system thrives or struggles. Join Paula Phillips (SVP, Operations Infrastructure, Ascension), Bryan Fissel (CFO, Ascension Medical Group), and Bharat Sundaram (CEO, Hallmark Health Care Solutions) for an exclusive discussion…
Presented by:
